↑ Grab this Headline Animator

Recombinant Products Make Strides in 15 Billion Infertility Drug Market

May 16, 2005 -- The world market for pharmaceuticals used in infertility management will garner $1.5 billion in revenues in 2005, according to a new market research report Markets in Human Reproductive Medicine: Contraception and Infertility Management released earlier this month from Kalorama Information. The increasing utilization of infertility treatments, the availability of more effective recombinant products replacing older urine-derived ones, and the advent of more convenient delivery devices are among the forces driving the market.



The new study, Markets in Human Reproductive Medicine: Contraception and Infertility Management, forecasts steady growth in the infertility management market, which is dominated by a few major players and is highly competitive. Product innovation within existing classes of drugs will be the main basis of competition in the near term, but revolutionary products are on the horizon.



"Researchers are upbeat about the prospects for new discoveries in reproductive science in the 21st century," notes Anne Anscomb, the author of the report. "Possible oral FSH, GnRH antagonists for manipulation of pituitary-gonadal function, and even treatments arising from research in other fields, are among some of the most intriguing developments."



In addition to pharmaceutical developments, the report also details markets and progress in assisted reproductive technologies (ARTs) such as IVF, GIFT, and ZIFT. The market for these technologies, which remain very expensive, is currently larger than the infertility pharmaceutical market. However, these technologies face multiple challenges including ethical concerns over the sharp increase in multifetal gestations and the nature and amount of reimbursement the procedures enjoy.



Priced at $3,500, this report can be purchased directly from Kalorama Information by clicking http://www.kaloramainformation.com/pub/1077871.html. It is also available at MarketResearch.com.



About Kalorama Information

Kalorama Information, an imprint of MarketResearch.com supplies the latest in independent market research for the life sciences. For more information, contact Steven Heffner at 212-807-2634 or e-mail protected from spam bots, or visit www.KaloramaInformation.com.



About MarketResearch.com

MarketResearch.com is the leading provider of global market intelligence products and services. With over 91,000 research publications from 350 research publishers, we offer instant online access to the world's most extensive database of expert insights on global industries. Updated daily. For more information, contact Irina Frukhtbeyn at 301-468-3650 x.203 or e-mail protected from spam bots, or visit www.MarketResearch.com.

↑ Grab this Headline Animator

---

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Evisionarts | Evisionarts Com | klocke allison leete |

---

4928 readers online...

, Local News